4Elmer GW.Probiotics:"living drugs"[J].Am J Health Syst Pharm,2001.58(12):1101-1109.
5Ruseler-van Embden JG.van Lieshout LM.Gosselink MJ.et al.Inability of Lactobcillus casei strain GG.L.acidophilus.and Bifidobacterium bifidum to degrade intestinal mucus plycoproteins [J].Scand J Gastroenterol.1995,30(7):675-680.
6Juntunen M.Kirjavainen PV.Ouwehand AC.et al.Adherence of probiotic bacteria fo human intestinal mucus in healthy infants and during rotavirus infection[J].Clin Diagn Lab Immunol.2001.8(2):293-296.
7Kailasapathy K.Chin J.Survival and therapeutic potential of probiotic organisms with referenac to Lactobacillus acidophilus and Bifidobacterium spp[J].Immunol Cell Biol.2000.78(1):80-88.
8Duffy LC.Zielezny MA.Riepenboff-Talty M.et al.Effectiveness of Bifidobacterium bifidum in mediating the clinical course of murine rotavirus diarrhea[J].Pediatr Rse.1994,35(6):690-695.
9Bevilcqua L.Ovidi M.Di Mattia E.et al.Screening of Bifidobacterium strains isolated from human faeces for antagonistic activitise against potentially bacterial pathogens[J].Microbiol Res,2003,158(2):179-185.
10Araki K.Shinozaki T.Irie Y.et al.Trial of oral administration of Bifidobacterium breve for the prevention of rotavirus infections [J].Kansenshogaku Zsshi .1999.73(4):305-310.
